eslicarbazepine acetate has been researched along with lacosamide in 13 studies
| Studies (eslicarbazepine acetate) | Trials (eslicarbazepine acetate) | Recent Studies (post-2010) (eslicarbazepine acetate) | Studies (lacosamide) | Trials (lacosamide) | Recent Studies (post-2010) (lacosamide) |
|---|---|---|---|---|---|
| 229 | 68 | 175 | 727 | 90 | 625 |
| Protein | Taxonomy | eslicarbazepine acetate (IC50) | lacosamide (IC50) |
|---|---|---|---|
| Sodium channel protein type 3 subunit alpha | Rattus norvegicus (Norway rat) | 0.415 | |
| Sodium channel protein type 9 subunit alpha | Homo sapiens (human) | 0.182 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (84.62) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Szupera, Z | 1 |
| Berry, DJ; Patsalos, PN | 1 |
| Cimadevilla, JM; Fernández-Pérez, J; Payán-Ortiz, M; Quiroga-Subirana, P; Serrano-Castro, PJ | 1 |
| Fadda, V; Giovannelli, F; Maratea, D; Verrotti, A; Zaccara, G | 1 |
| Brodie, MJ | 1 |
| Mula, M | 1 |
| Bragazzi, NL; Brigo, F; Nardone, R; Trinka, E | 1 |
| Brodie, MJ; Stephen, LJ; Wishart, A | 1 |
| Johnson, EL; Krauss, GL; Kwok, CS | 1 |
| Rocha, JF; Soares-da-Silva, P; Trinka, E | 1 |
| Brigo, F; Lattanzi, S | 1 |
| Bialer, M; Franco, V; Odi, R; Perucca, E | 1 |
| Brigo, F; Del Giovane, C; Lattanzi, S; Russo, E; Silvestrini, M; Striano, P; Trinka, E; Zaccara, G | 1 |
9 review(s) available for eslicarbazepine acetate and lacosamide
| Article | Year |
|---|---|
[New antiepileptic drugs, and therapeutic considerations].
Topics: Acetamides; Anticonvulsants; Carbamates; Dibenzazepines; Epilepsy; Humans; Lacosamide; Phenylenediamines | 2011 |
Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate.
Topics: Acetamides; Anticonvulsants; Carbamates; Dibenzazepines; Drug Interactions; Epilepsy; Humans; Lacosamide; Phenylenediamines | 2012 |
Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
Topics: Acetamides; Anticonvulsants; Ataxia; Carbamazepine; Dibenzazepines; Diplopia; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Lacosamide; Nervous System Diseases; Oxcarbazepine; Randomized Controlled Trials as Topic; Risk Assessment; Sodium Channel Blockers; Treatment Outcome | 2013 |
Practical Use of Newer Antiepileptic Drugs as Adjunctive Therapy in Focal Epilepsy.
Topics: Acetamides; Adult; Aged; Animals; Anticonvulsants; Carbamates; Dibenzazepines; Drug Resistant Epilepsy; Epilepsies, Partial; Female; Humans; Lacosamide; Male; Middle Aged; Nitriles; Phenylenediamines; Pyridones | 2015 |
Third generation antiepileptic drug monotherapies in adults with epilepsy.
Topics: Acetamides; Adult; Anticonvulsants; Dibenzazepines; Epilepsy; Humans; Lacosamide; Time Factors | 2016 |
Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs.
Topics: Acetamides; Anticonvulsants; Dibenzazepines; Drug Therapy, Combination; Epilepsies, Partial; Humans; Lacosamide; Nitriles; Pyridones; Pyrrolidinones; Randomized Controlled Trials as Topic | 2016 |
Comparing Safety and Efficacy of "Third-Generation" Antiepileptic Drugs: Long-Term Extension and Post-marketing Treatment.
Topics: Acetamides; Anticonvulsants; Dibenzazepines; Drug-Related Side Effects and Adverse Reactions; Follow-Up Studies; Humans; Lacosamide; Longitudinal Studies; Medication Adherence; Nitriles; Product Surveillance, Postmarketing; Pyridones; Pyrrolidinones; Seizures | 2017 |
Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in Europe.
Topics: Anticonvulsants; Area Under Curve; Biological Variation, Individual; Dibenzazepines; Drug Substitution; Drugs, Generic; Europe; Gabapentin; Humans; Lacosamide; Lamotrigine; Levetiracetam; Oxcarbazepine; Pregabalin; Therapeutic Equivalency; Topiramate; Vigabatrin; Zonisamide | 2021 |
Third-Generation Antiseizure Medications for Adjunctive Treatment of Focal-Onset Seizures in Adults: A Systematic Review and Network Meta-analysis.
Topics: Adult; Anticonvulsants; Carbamates; Chlorophenols; Dibenzazepines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lacosamide; Male; Middle Aged; Network Meta-Analysis; Nitriles; Pyridones; Pyrrolidinones; Randomized Controlled Trials as Topic; Seizures; Tetrazoles | 2022 |
1 trial(s) available for eslicarbazepine acetate and lacosamide
| Article | Year |
|---|---|
[Eslicarbazepine acetate in clinical practice. Efficacy and safety results].
Topics: Acetamides; Adolescent; Adult; Aged; Anticonvulsants; Cognition Disorders; Depression; Dibenzazepines; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; Female; Follow-Up Studies; Humans; Lacosamide; Male; Middle Aged; Sodium Channel Blockers; Weight Gain; Young Adult | 2013 |
3 other study(ies) available for eslicarbazepine acetate and lacosamide
| Article | Year |
|---|---|
Psychiatric side effects and antiepileptic drugs: Observations from prospective audits.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Dibenzazepines; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; Fructose; Humans; Lacosamide; Levetiracetam; Male; Medical Audit; Mental Disorders; Middle Aged; Nitriles; Piracetam; Pregabalin; Prospective Studies; Pyridones; Retrospective Studies; Seizures; Sodium Channel Blockers; Topiramate; Young Adult | 2017 |
Response: Comparing the dosages of lacosamide, eslicarbazepine acetate, and controlled-release carbamazepine in noninferiority epilepsy monotherapy trials: How much "fair" is "fair".
Topics: Acetamides; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dibenzazepines; Epilepsy; Humans; Lacosamide | 2018 |
Comparing the dosages of lacosamide, eslicarbazepine acetate, and controlled-release carbamazepine in noninferiority epilepsy monotherapy trials: How much "fair" is "fair"?
Topics: Acetamides; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dibenzazepines; Epilepsy; Humans; Lacosamide | 2018 |